Evidence map›Paper›PMID 32279690›Full record

Trial reportThe British journal of nutrition2020

Resistant starch supplementation increases crypt cell proliferative state in the rectal mucosa of older healthy participants.

Fiona C Malcomson, Naomi D Willis, Iain McCallum, Long Xie, Arthur C Ouwehand, Julian D Stowell, Seamus Kelly, D Michael Bradburn, Nigel J Belshaw, Ian T Johnson and 1 more

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The British journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Synthesis and Functions of Resistant Starch.Advances in nutrition (Bethesda, Md.) · 2023
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Fiona C MalcomsonHuman Nutrition Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon TyneNE2 4HH, UK.ORCID 0000-0001-5072-7644
Naomi D WillisHuman Nutrition Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon TyneNE2 4HH, UK.
Iain McCallumNorthumbria Healthcare NHS Foundation Trust, North ShieldsNE29 8NH, UK.
Long XieHuman Nutrition Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon TyneNE2 4HH, UK.
Arthur C OuwehandDuPont Nutrition & Biosciences, 02460Kantvik, Finland.
Julian D StowellDuPont Nutrition & Biosciences, ReigateRH2 9PQ, UK.
Seamus KellyNorthumbria Healthcare NHS Foundation Trust, North ShieldsNE29 8NH, UK.
D Michael BradburnNorthumbria Healthcare NHS Foundation Trust, AshingtonNE63 9JJ, UK.
Nigel J BelshawUniversity of East Anglia, Norwich Research Park, NorwichNR4 7TJ, UK.
Ian T JohnsonQuadram Institute, Norwich Research Park, NorwichNR4 7UQ, UK.
John C MathersHuman Nutrition Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon TyneNE2 4HH, UK.
Newcastle University · GBNorthumbria Healthcare NHS Foundation Trust · GBDuPont (Finland) · FIDuPont (United Kingdom) · GBNorwich Research Park · GBUniversity of East Anglia · GB

Funding

Biotechnology and Biological Sciences Research Council BB/H005013/1Medical Research Council MR/L016354/1Wellcome Trust
6 · The paper itself

Abstract

There is strong evidence that foods containing dietary fibre protect against colorectal cancer, resulting at least in part from its anti-proliferative properties. This study aimed to investigate the effects of supplementation with two non-digestible carbohydrates, resistant starch (RS) and polydextrose (PD), on crypt cell proliferative state (CCPS) in the macroscopically normal rectal mucosa of healthy individuals. We also investigated relationships between expression of regulators of apoptosis and of the cell cycle on markers of CCPS. Seventy-five healthy participants were supplemented with RS and/or PD or placebo for 50 d in a 2 × 2 factorial design in a randomised, double-blind, placebo-controlled trial (the Dietary Intervention, Stem cells and Colorectal Cancer (DISC) Study). CCPS was assessed, and the expression of regulators of the cell cycle and of apoptosis was measured by quantitative PCR in rectal mucosal biopsies. SCFA concentrations were quantified in faecal samples collected pre- and post-intervention. Supplementation with RS increased the total number of mitotic cells within the crypt by 60 % (P = 0·001) compared with placebo. This effect was limited to older participants (aged ≥50 years). No other differences were observed for the treatments with PD or RS as compared with their respective controls. PD did not influence any of the measured variables. RS, however, increased cell proliferation in the crypts of the macroscopically-normal rectum of older adults. Our findings suggest that the effects of RS on CCPS are not only dose, type of RS and health status-specific but are also influenced by age.

Indexed as

Dietary SupplementsAberrant Crypt FociAdultAgedAged, 80 and overCell ProliferationColonic NeoplasmsDouble-Blind MethodFecesFemaleGlucansHealthy VolunteersHumansIntestinal MucosaMaleMiddle AgedGlucanspolydextroseStarchApoptosisColorectal cancer riskCrypt cell proliferationDietary fibrePolydextroseResistant starch

Identifiers

PMID32279690
PMCPMC7369377
OpenAlexW3015557683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.